Matt DeNardo
speaker
183 appearances
1 recordings
1 series
first heard Jul 2026
last heard 11 Jul
Matt DeNardo’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
And I think bought into the idea that this is potentially something
a life-changing technology for some of these patients and wanted to be on board with helping advance it even further.
The second thing that I note is the facilities at the hospital in Panama that we worked with were state of the art.
And I think in neurosurgery and brain computer interface technology specifically, that having facilities that are modern, especially in terms of
How they perform with respect to electrical noise is really important for this very sensitive technology that we're trying to bring to market.
So neuromonitoring devices and brain-computer interfaces in general
are very susceptible to environmental noise.
And so for use intraoperatively in an operating room with a bunch of other medical equipment that's being used at the same time is we had to understand what the noise performance of the room and the space, the environment, and the other devices in the environment were.
And having a more modern facility tends to mean that everything from construction standards to practices in the operating room and the relative radio frequency immunity of the devices that we're working with and what kind of radio frequency noise spectrum they produce is much more understood and controlled in such an environment.
And then finally, the last thing that really appealed to us was a bit of good fortune in that from Boston to Panama City was a direct flight.
And I think...
It was something that was not certainly our first decision criterion, but in now having lived through that experience, I can't overstate how important that was to be able to get a team to and from our clinical site within the same day.
And I think for other sites farther south in Latin America, that was challenging.
Either physically they were too far away or that just flight schedules...
Always required a layover and that layover could extend the trip for another day.
And so the difference between being able to fly down and, you know, arrive in the evening, meet with the clinicians and be prepared for a procedure the next day.
is something that we're able to do in Panama where traveling to a farther location or having extra layovers would not have made that possible.
It would have been a two-day process in and out.
So it changes you from being able to do potentially two or even three procedures a week in Panama to a place where we might only be able to do one.
And that's a really big difference, certainly for first-in-human trial where you want to make multiple trips because you're basically doing a very controlled release.
Showing 61–80 of 183 · page 4 of 10
← Previous
Next →